Checkmate Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VENBIO PARTNERS LLC | 05/16/2022 | 3.67 M | $11.72 M | 0.00% | 16.98% |
SOFINNOVA INVESTMENTS, INC. | 05/16/2022 | 3.61 M | $11.51 M | 0.00% | 16.67% |
NOVO HOLDINGS A/S | 05/27/2022 | 2.16 M | $6.90 M | -0.37% | 10.00% |
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 05/12/2022 | 1.50 M | $4.79 M | 0.00% | 6.94% |
OMEGA FUND MANAGEMENT, LLC | 05/13/2022 | 1.34 M | $4.26 M | 0.00% | 6.17% |
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC | 05/10/2022 | 1.33 M | $4.25 M | 100.00% | 6.16% |
CLOUGH CAPITAL PARTNERS L P | 05/16/2022 | 1.14 M | $3.63 M | -12.92% | 5.26% |
FMR LLC | 05/13/2022 | 966.23 K | $3.08 M | -0.10% | 4.47% |
VANGUARD GROUP INC | 05/13/2022 | 556.42 K | $1.78 M | -4.04% | 2.57% |
SECTORAL ASSET MANAGEMENT INC | 05/10/2022 | 541.77 K | $1.73 M | 0.00% | 2.50% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/16/2022 | 106.50 K | $340.00 K | 0.00% | 0.49% |
RBF CAPITAL, LLC | 05/16/2022 | 68.03 K | $219.00 K | 0.00% | 0.31% |
BLACKROCK INC. | 05/12/2022 | 51.33 K | $164.00 K | -1.98% | 0.24% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2022 | 41.47 K | $132.00 K | 3.00% | 0.19% |
FEDERATED HERMES, INC. | 05/13/2022 | 30.64 K | $98.00 K | 1.81% | 0.14% |
CAMBRIDGE TRUST CO | 05/12/2022 | 24.61 K | $79.00 K | 0.00% | 0.11% |
BARCLAYS PLC | 05/16/2022 | 14.55 K | $46.00 K | 100.00% | 0.07% |
STATE STREET CORP | 05/16/2022 | 11.42 K | $36.00 K | 3.04% | 0.05% |
MORGAN STANLEY | 10/27/2022 | 3.01 K | $10.00 K | -26.26% | 0.01% |
US BANCORP \DE\ | 05/11/2022 | 2.00 K | $6.00 K | 0.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/12/2022 | 1.94 K | $6.00 K | 100.00% | 0.01% |
JOHNSON MIDWEST FINANCIAL, LLC | 04/13/2022 | 200 | $1.00 K | 0.00% | 0.00% |
UBS GROUP AG | 05/16/2022 | 183 | $1.00 K | -83.44% | 0.00% |
JPMORGAN CHASE & CO | 05/11/2022 | 49 | $0 | 100.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 05/16/2022 | 33 | $0 | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/16/2022 | 0 | $0 | -100.00% | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/09/2022 | 0 | $0 | 0.00% | 0.00% |
ROYAL BANK OF CANADA | 05/16/2022 | 0 | $0 | -100.00% | 0.00% |
MILLENNIUM MANAGEMENT LLC | 05/16/2022 | 0 | $0 | -100.00% | 0.00% |
ENSIGN PEAK ADVISORS, INC | 05/16/2022 | 0 | $0 | -100.00% | 0.00% |
Checkmate Pharmaceuticals, Inc. institutional Ownership - FAQ's
79.38% of Checkmate Pharmaceuticals, Inc. stock is owned by institutional investors.